Generic Portal

Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19

COBRA KAI Study Team, Haggenburg, S., Hofsink, Q., Lissenberg-Witte, B. I., Broers, A. E. C., van Doesum, J. A., van Binnendijk, R. S., den Hartog, G., Bhoekhan, M. S., Haverkate, N. J. E., Burger, J. A., Bouhuijs, J. H., Smits, G. P., Wouters, D., van Leeuwen, E. M. M., Bontkes, H. J., Kootstra, N. A., Zweegman, S., Kater, A. P., Heemskerk, M. H. M., & 9 othersGroen, K., van Meerten, T., Mutsaers, P. G. N. J., Beaumont, T., van Gils, M. J., Goorhuis, A., Rutten, C. E., Hazenberg, M. D. & Nijhof, I. S., 1 Oct 2022, In: JAMA oncology. 8, 10, p. 1477-1483 7 p.

Research output: Contribution to journal › Article › Academic › peer-review

CLL-106 First Prospective Data on Minimal Residual Disease Outcomes After Fixed-Duration Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for First-Line Treatment of CLL in Older Adult or Unfit Patients: The GLOW Study

Munir, T., Moreno, C., Owen, C., Follows, G., Benjamini, O., Janssens, A., Levin, M-D., Osterborg, A., Robak, T., Simkovic, M., Stevens, D., Voloshin, S., Vorobyev, V., Yagci, M., Ysebaert, L., Qi, Q., Steele, A., Schuier, N., Baeten, K., Caces, D. B., & 2 othersNiemann, C. & Kater, A., 1 Oct 2022, In: Clinical lymphoma, myeloma & leukemia. 22, p. S264-S265

Research output: Contribution to journal › Article › Academic › peer-review

Fel d 1 surface expression on plant-made eBioparticles combines potent immune activation and hypoallergenicity

Busold, S., Aglas, L., Menage, C., Auger, L., Desgagnés, R. J., Faye, L., Fitchette, A-C., de Jong, E. C., Martel, C., Stigler, M., Catala-Stordeur, V., Tropper, G., Vézina, L-P., Gomord, V. R., Geijtenbeek, T. B. H. & van Ree, R., Oct 2022, In: Allergy: European Journal of Allergy and Clinical Immunology. 77, 10, p. 3124-3126 3 p.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Improving naive B cell isolation by absence of CD45RB glycosylation and CD27 expression in combination with BCR isotype

Koers, J., Pollastro, S., Tol, S., Niewold, I. T. G., van Schouwenburg, P. A., de Vries, N. & Rispens, T., Oct 2022, In: European journal of immunology. 52, 10, p. 1630-1639 10 p.

Research output: Contribution to journal › Article › Academic › peer-review

Longitudinal analysis of anti-drug antibody development in multiple sclerosis patients treated with interferon beta-1a (Rebif™) using B cell receptor repertoire analysis

van der Weele, L., Pollastro, S., van Schaik, B. D. C., van Kampen, A. H. C., Niewold, I. T. G., Kuijpers, T. W., Warnke, C., Jensen, P. E. H., Kramer, D., Ryner, M., Hermanrud, C., Dönnes, P., Pallardy, M., Spindeldreher, S., on behalf of the ABIRISK Consortium, Deisenhammer, F., Fogdell-Hahn, A. & de Vries, N., 15 Sep 2022, In: Journal of neuroimmunology. 370, 577932.

Research output: Contribution to journal › Article › Academic › peer-review

Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases

Stalman, E. W., Wieske, L., van Dam, K. P. J., Kummer, L. Y., van Kempen, Z. L. E., Killestein, J., Volkers, A. G., Tas, S. W., Boekel, L., Wolbink, G. J., van der Kooi, A. J., Raaphorst, J., Löwenberg, M., Takkenberg, R. B., D'Haens, G. R. A. M., Spuls, P. I., Bekkenk, M. W., Musters, A. H., Post, N. F., Bosma, A. L., & 39 othersHilhorst, M. L., Vegting, Y., Bemelman, F. J., Voskuyl, A. E., Broens, B., Parra Sanchez, A., van Els, C. C. A. C. M., Wit, J. D., Rutgers, A., de Leeuw, K., Horváth, B., Verschuuren, J. J. G. M., Ruiter, A. M., van Ouwerkerk, L., van der Woude, D., Allaart, C. F., Teng, O. Y. K., van Paassen, P., Busch, M. H., Jallah, P. B. P., Brusse, E., van Doorn, P. A., Baars, A. E., Hijnen, D. J., Schreurs, C. R. G., van der Pol, W. L., Goedee, H. S., Steenhuis, M., Keijzer, S., Keijser, J. B. D., Boogaard, A., Cristianawati, O., ten Brinke, A., Verstegen, N. J. M., Zwinderman, K. A. H., Rispens, T., van Ham, S. M., Kuijpers, T. W. & Eftimov, F., 5 Sep 2022, In: Annals of the rheumatic diseases. 81, 12, p. 1757-1766 10 p., 222904.

Research output: Contribution to journal › Article › Academic › peer-review

Extrathymic AIRE-expressing cells: Friends or foes in autoimmunity and cancer?

van Laar, G. G., van Hamburg, J. P. & Tas, S. W., 1 Sep 2022, In: Autoimmunity reviews. 21, 9, 103141.

Research output: Contribution to journal › Review article › Academic › peer-review

Managing food allergy: GA2LEN guideline 2022

GA2LEN Food Allergy Guideline Group, 1 Sep 2022, In: World Allergy Organization journal. 15, 9, 100687.

Research output: Contribution to journal › Review article › Academic › peer-review

Enhanced Costimulatory Signaling Improves CAR T-cell Effector Responses in CLL

Collins, M. A., Jung, I-Y., Zhao, Z., Apodaca, K., Kong, W., Lundh, S., Fraietta, J. A., Kater, A. P., Sun, C., Wiestner, A. & Melenhorst, J. J., Sep 2022, In: Cancer research communications. 2, 9, p. 1089-1103 15 p.

Research output: Contribution to journal › Article › Academic › peer-review

Risk factors for severe reactions in food allergy: Rapid evidence review with meta-analysis

the Global Allergy, Asthma European Network (GA2LEN) Food Allergy Guideline Group, Sep 2022, In: Allergy: European Journal of Allergy and Clinical Immunology. 77, 9, p. 2634-2652 19 p.

Research output: Contribution to journal › Review article › Academic › peer-review